Picture a 65-year-old retiree whose knees ache too much for a morning walk but whose doctor keeps warning about creeping blood pressure. A year-long clinical trial published in early 2026 suggests she has a credible alternative: baduanjin, a centuries-old Chinese routine of eight slow, standing movements paired with deep breathing, lowered 24-hour systolic blood pressure by roughly the same margin as brisk walking in 216 adults tracked across seven Beijing medical centers.
The finding, reported in the Journal of the American College of Cardiology (JACC), matters because the participants occupied a risk zone familiar to millions: systolic readings between 130 and 139 mm Hg. Under current American Heart Association guidelines, that range qualifies as Stage 1 hypertension and raises the odds of heart attack and stroke even when people feel perfectly fine. For those who struggle with joint pain, poor balance, or limited access to sidewalks and gyms, a gentle indoor routine that requires no equipment could remove one of the biggest barriers to actually doing something about it.
What the BLESS trial found
The study, called BLESS (Baduanjin Lowers Elevated Systolic blood pressure Study), was a multicenter, three-arm randomized controlled trial. Researchers enrolled adults aged 40 and older and randomly assigned them to one of three groups: supervised baduanjin classes, supervised brisk walking sessions, or a self-directed exercise control group that received general advice about staying active but no structured program.
Over 52 weeks, both the baduanjin and brisk walking groups showed reductions in 24-hour ambulatory systolic blood pressure that clearly outperformed the control group. Critically, the two active interventions performed similarly to each other. The drops were in the low single-digit millimeters-of-mercury range, which may sound small on paper but align with what large-scale evidence says about exercise and blood pressure.
A dose-response meta-analysis of randomized trials published in Hypertension Research found that moderate aerobic activity typically produces reductions of a similar magnitude in people with hypertension. At the population level, even a 2 mm Hg drop in systolic pressure is associated with measurable decreases in stroke and coronary events. The BLESS numbers sit squarely in that range, reinforcing the idea that the effect is real rather than a statistical fluke.
Because the primary outcome relied on ambulatory monitors worn for 24 hours rather than a single reading in a clinic, the results are less vulnerable to white-coat spikes or random day-to-day swings. That design choice gives the findings more weight than many earlier exercise-and-blood-pressure studies that depended on office measurements alone.
What baduanjin actually looks like
Baduanjin (pronounced roughly “bah-dwahn-jin”) translates to “eight pieces of brocade,” a reference to its eight distinct postures. Each movement involves a slow, deliberate stretch coordinated with rhythmic breathing: pressing palms skyward, drawing a bow on each side, raising one arm while pressing the other down, and so on. A full session typically lasts 20 to 30 minutes. The pace is unhurried, the range of motion is moderate, and the impact on joints is minimal compared with walking or jogging.
The routine has roots in China’s Song Dynasty (roughly 960 to 1279 CE) and remains one of the most widely practiced forms of health qigong in Chinese parks and community centers. In the BLESS protocol, participants attended structured classes several times per week, guided by trained instructors who standardized posture, breathing, and pacing. The brisk walking group followed a more conventional prescription: walking at a pace that pushed heart rate into a moderate-intensity zone, also under supervision.
That supervision matters. Earlier pooled analyses, including a systematic review in BMC Complementary Medicine and Therapies, had already suggested baduanjin could lower blood pressure, but many of the underlying studies were small, short, and published in Chinese-language journals with limited peer review visibility. Because those trials varied in methodological rigor, the pooled results should be treated as suggestive rather than definitive; the inclusion of lower-quality studies means the true average effect could be smaller than the meta-analysis headline number implies. The BLESS trial builds on that foundation with a longer follow-up, a head-to-head active comparator, and publication in a top-tier cardiology journal, providing stronger standalone evidence.
Important caveats and open questions
Several gaps prevent anyone from calling baduanjin a proven replacement for conventional exercise or medication.
Population limits. Every participant in the BLESS trial was a Chinese adult living in Beijing. Whether the same blood pressure benefits hold across different ethnic groups, body compositions, and dietary patterns has not been tested in a controlled setting. Known differences in salt sensitivity and hypertension prevalence across populations make extrapolation risky.
No long-term follow-up. The trial lasted 52 weeks, but no data exist on whether participants maintained their practice, or their blood pressure improvements, after the supervised phase ended. Exercise programs of all types suffer from dropout, and a two-year or five-year follow-up would clarify whether baduanjin offers durable protection or a temporary effect that fades once structured support disappears.
Mechanism unclear. The BLESS trial showed that baduanjin matched brisk walking, but it did not isolate why. Is the benefit driven by the stretching, the deep breathing, the meditative focus, or some combination? Some researchers have hypothesized that the stretching component alone may account for a significant share of the blood pressure effect, but no trial has yet isolated baduanjin’s individual elements head to head. Until that work is done, the active ingredient remains an open question.
Dose and drug interactions unknown. The trial used a specific schedule and standardized routine. Whether shorter or less frequent sessions would work, or whether more practice would produce larger benefits, has not been established. Nor has any trial examined how baduanjin interacts with common antihypertensive medications, which many people in this blood pressure range eventually start taking.
No cost-effectiveness data. Baduanjin is free to perform once learned, but the BLESS trial relied on trained instructors at seven clinical sites. Whether community classes, online videos, or app-guided sessions can replicate the same results is untested. Health systems cannot yet calculate whether promoting baduanjin would save money compared with standard exercise counseling or nurse-led walking programs.
Who might benefit most
The practical takeaway is not that everyone should swap their running shoes for qigong. People who already enjoy walking, cycling, or other aerobic exercise have no strong reason, based on current data, to switch. The cardiovascular benefits of vigorous activity extend well beyond blood pressure, including improvements in aerobic capacity, metabolic health, and muscular strength that baduanjin has not been shown to match.
Where baduanjin fills a genuine gap is for adults who face real barriers to conventional exercise: chronic joint pain, poor balance, limited outdoor access, or simply a deep aversion to gyms and structured fitness programs. For someone whose alternative is doing nothing, a 20-minute standing routine in a living room represents a meaningful step toward blood pressure control. Clinicians can present it as one evidence-based tool in a broader toolkit, while being transparent that the data, though promising, come from a single geographic population and a single year of follow-up.
Where the research goes from here
The next wave of studies will need to test baduanjin in different countries and healthcare settings, track adherence and outcomes over several years, and examine how this traditional practice fits alongside modern medications and lifestyle programs. For now, the evidence supports a cautious but genuinely encouraging conclusion: for adults on the cusp of hypertension, a gentle sequence of eight standing movements may lower blood pressure about as well as a brisk daily walk. And for the people most likely to skip that walk, that could be the detail that finally gets them moving.
More from Morning Overview
*This article was researched with the help of AI, with human editors creating the final content.
